Competition

  • July 09, 2026

    Blue Origin's Valuation Soars To $130B, Plus More Rumors

    Blue Origin's valuation hit $130 billion after a $10 billion funding round; state lawyers are finalizing an antitrust lawsuit related to Paramount's planned takeover of Warner Bros. Discovery; and Fiserv is considering selling its payments infrastructure business to U.S. banking giants.

  • July 09, 2026

    Actavis Can't Escape State AG Generic Drug Claims

    A Connecticut federal court has trimmed several claims from state enforcers accusing Actavis of fixing prices for dermatology drug products but allowed most of the claims against the drugmaker to proceed.

  • July 09, 2026

    Austria's Bank VAT Break Was State Aid, EU Top Court Says

    The European Union's top court ruled Thursday against an Austrian law that provided a value-added tax exemption for certain transactions in the banking and insurance sectors, holding that the tax break functioned as illegal state aid under EU law.

  • July 09, 2026

    NJ Looks To Renew RealPage Antitrust Claims Against REIT

    New Jersey has asked the state's federal court to allow it to file an amended complaint that fixes the pleading issues in its suit accusing multifamily real estate investment trust AvalonBay Communities Inc. of using RealPage Inc.'s revenue management software in a residential rent price-fixing scheme. 

  • July 09, 2026

    Limits On Sports Agents Might Not Flout EU's Anti-Cartel Rules

    Restrictions from sports federations on the activities of players' agents may be exempt from the European Union's rules against cartels if the rules aim to protect the public interest, the bloc's top court ruled Thursday.

  • July 08, 2026

    Samsung Accuses Netlist Of Patent 'Double-Dip' In Latest Suit

    Samsung has kicked off yet another lawsuit in its long-running intellectual property dispute with Netlist, this time claiming that Netlist is trying to "double dip" with a demand that Samsung take a second license to Netlist's patents covering semiconductor technology, according to a complaint filed in Delaware federal court Wednesday.

  • July 08, 2026

    Citi Should Be Shrinking, Not Shopping, Sen. Warren Says

    If Citigroup thinks now is a good time to expand its "financial empire" with a major acquisition, its already-mammoth size and past compliance troubles should make it think again, the top Democrat on the U.S. Senate Banking Committee told the bank on Wednesday.

  • July 08, 2026

    Amazon Ordered To Give FTC Docs It Claimed Were Privileged

    A Washington federal judge ordered Amazon to give the Federal Trade Commission several documents sought in the agency's antitrust case and said a "re-review" of the online retailer's discovery is needed to ensure the company "does not continue to withhold documents based on an improper application of the attorney-client privilege."

  • July 08, 2026

    Snack Cos. Say DOJ Deal Demands Price-Fix Verdict Revisit

    Kraft, Kellogg, Nestle and General Mills want an Illinois federal judge to schedule a status conference "imminently" in their long-running antitrust suit to ask Cal-Maine Foods Inc. about a deal it recently reached with the government over claims it inflated the price of eggs and how it affects their $53 million jury verdict.

  • July 08, 2026

    Butterball, 2 More Head For Ill. Turkey Price-Fix Trials

    An Illinois federal judge handling consolidated turkey price-fixing litigation has teed up two trials against Butterball and two other major producers as he works through a pile of summary judgment challenges from defendants looking to avoid jury trials.

  • July 08, 2026

    Fans Say They're Entitled To Discovery From Past UFC Cases

    Fans accusing Ultimate Fighting Championship of monopolizing the market for mixed martial arts pay-per-view events said Wednesday they are entitled to access discovery from a set of previous antitrust cases called the "fighter cases."

  • July 08, 2026

    Georgia Healthcare Co. Says Ex-Staff Stole Patient Records

    Two former employees of a Georgia-based healthcare company stole patient and caretaker compensation data days before leaving the company's Pueblo, Colorado, branch for one of its rivals, according to the healthcare company's complaint filed in Colorado federal court Wednesday.

  • July 08, 2026

    RealPage And Willow Bridge Face Class Claims After DOJ Deal

    RealPage and Texas-based Willow Bridge Property Company have been hit with class claims alleging they violated Philadelphia's prohibition on the coordination of residential rents by collecting and using non-public data on rates charged by competing landlords.

  • July 08, 2026

    Archer Looks To Toss Remainder Of Joby's Trade Secret Suit

    Archer Aviation has asked a California federal judge to throw out what's left of rival electric air taxi-maker Joby Aviation's trade secret suit, saying Joby had ignored the court's instructions to proceed with narrowed claims and instead tried to expand its allegations without adding more substance.

  • July 08, 2026

    Turf Co. Drops Trade Secrets Suit Against Former Exec

    Turf manufacturer FieldTurf USA has agreed to dismiss its lawsuit accusing one of its former executives of taking confidential information when he jumped ship to work for a rival company.

  • July 08, 2026

    NC Realty Co. And Mortgage Lender Must Face Kickback Suit

    A realty company and a mortgage lender accused of running an unlawful kickback scheme couldn't secure a pretrial win after a North Carolina federal judge found a homebuyer alleged enough to confer standing under federal consumer protection law.

  • July 08, 2026

    FTC Can't Get Zillow-Redfin Deal Held Illegal Before Trial

    A Virginia federal judge refused in a bench ruling Wednesday to limit Zillow and Redfin's ability to defend a rental listings syndication deal the Federal Trade Commission says was a $100 million payoff for Redfin to exit the market, teeing up "multiple" factual disputes for trial next month.

  • July 08, 2026

    PBMs Fight Bid To Add Pharmacy Group To Price-Fixing Suit

    Two pharmacy benefit managers have told a Michigan federal judge that a trade association for small pharmacies should not be allowed to intervene in a price-fixing lawsuit brought by the state's attorney general.

  • July 08, 2026

    FTC, States Settle John Deere Right-To-Repair Case

    The Federal Trade Commission and state enforcers reached a deal Wednesday to settle an antitrust case accusing John Deere of restricting equipment repairs, after the company agreed to give farmers and independent technicians the resources it provides to authorized dealers.

  • July 08, 2026

    $17.5M Amex Antisteering Deal Is Approved

    A New York federal court this week approved a $17.5 million settlement with American Express Co. in a lawsuit alleging that the credit card company's so-called antisteering rules caused non-Amex cardholders to pay higher charges.

  • July 08, 2026

    Vax Skeptics Push To Advance Publisher Boycott Claims

    A vaccine skepticism advocacy group once tied to Secretary of Health and Human Services Robert F. Kennedy Jr. told a D.C. federal court it's considering a mandamus petition to move forward its lawsuit claiming news organizations colluded with social media platforms to censor rivals.

  • July 07, 2026

    6th Circ. Says MillerKnoll Owns Rights To Iconic Lamp Design

    The Sixth Circuit Tuesday refused to disturb a lower court's decision awarding intellectual property rights for late designer George Nelson's iconic bubble lamp to furniture company MillerKnoll, ruling that a 2006 royalty agreement authorized the company to use and own those rights.

  • July 07, 2026

    Regeneron Ducks Amgen's Eylea Antitrust Counterclaims

    A West Virginia federal judge dismissed key counterclaims and defenses Tuesday that Amgen had raised against Regeneron's patent infringement lawsuit targeting bids by multiple would-be rivals to produce biosimilar versions of eye medication Eylea, preserving only arguments that Regeneron waited too long to pursue the patent.

  • July 07, 2026

    Align's Invisalign Patents Are Infringed But Invalid, Jury Finds

    A Texas federal jury has found that claims in four patents Invisalign maker Align Technology Inc. asserted against orthodontics company ClearCorrect were invalid, but the jurors also rejected ClearCorrect's antitrust claims against Align.

  • July 07, 2026

    Ill. Judge Approves $37M More In PVC Price-Fix Deals

    An Illinois federal judge gave her early approval Tuesday to more than $37 million in settlements two classes struck with a company defending against accusations that it participated in an illegal price-fixing scheme with other major polyvinyl chloride pipe producers.

Expert Analysis

  • CFIUS Initiative May Smooth Way For Some Foreign Investors

    Author Photo

    A new program that will allow certain foreign investors to be prevetted and admitted to fast-track approval by the Committee on Foreign Investment in the United States will likely have tangible benefits for investors participating in competitive M&A, say attorneys at Simpson Thacher.

  • Series

    Judges On AI: Practical Use Cases In Chambers

    Author Photo

    U.S. Magistrate Judge Allison Goddard in the Southern District of California discusses how she uses generative artificial intelligence tools in chambers to make work more efficient and effective — from editing jury instructions for clarity to summarizing key documents.

  • Takeaways From 1st DOJ Antitrust Whistleblower Payout

    Author Photo

    The U.S. Justice Department's recent $1 million antitrust whistleblower reward accelerates the race to report by signaling that the Antitrust Division's program can result in substantial financial awards and reinforcing the need for corporate compliance programs that reach beyond core components, say attorneys at Pillsbury.

  • Series

    Trail Running Makes Me A Better Lawyer

    Author Photo

    Navigating the muddy, root-filled path of trail marathons and ultramarathons provides fertile training ground for my high-stakes fractional general counsel work, teaching me to slow down my mind when the terrain shifts, sharpen my focus and trust my training, says Eric Proos at Next Era Legal.

  • Navigating New Risks Amid Altered Foreign Issuer Landscape

    Author Photo

    The U.S. Securities and Exchange Commission's potential rulemaking to redefine who qualifies as a foreign private issuer will shape securities regulation and enforcement for decades, affecting not only FPIs and U.S. investors but also the U.S.' position in global capital markets, says Elisha Kobre at Sheppard.

  • Reflections From High Court Oral Args Over Fed Gov. Removal

    Author Photo

    In the oral arguments last month for Trump v. Cook, which asks the U.S. Supreme Court to clarify the circumstances under which the president can remove a Federal Reserve Board governor, the justices appeared skeptical about ruling on the substantive issues in view of the limited record and analysis, say attorneys at Ballard Spahr.

  • CFIUS Risk Lessons From Chips Biz Divestment Order

    Author Photo

    President Donald Trump's January executive order directing HieFo to unwind its 2024 acquisition of a semiconductor business with ties to China underscores that even modestly sized transactions can attract CFIUS interest if they could affect strategic areas prioritized by the U.S. government, say attorneys at Debevoise.

  • Malpractice Claim Assignability Continues To Divide Courts

    Author Photo

    Recent decisions from courts across the country demonstrate how different jurisdictions balance competing policy interests in determining whether legal malpractice claims can be assigned, providing a framework to identify when and how to challenge any attempted assignment, says Christopher Blazejewski at Sherin & Lodgen.

  • Tips For Financial Advisers Facing TRO From Former Firm

    Author Photo

    The Eighth Circuit's recent decision in Choreo v. Lors, overturning a lower court's sweeping injunction after financial advisers moved to a new firm, gives advisers new strategies to fight restraining orders from their old firms, such as focusing on whether the alleged irreparable harm is calculable, say attorneys at Kutak Rock.

  • How Latest Nasdaq Proposals Stand To Raise Listings Quality

    Author Photo

    Nasdaq's recent proposals stand to heighten both quantitative and qualitative standards for issuers, which, if approved, may bring investors stronger market integrity and access but also raise the listings bar, say attorneys at Norton Rose.

  • Opinion

    CFIUS Must Adapt To Current Foreign Investment Realities

    Author Photo

    To continue protecting the U.S.’ long-term strategic and economic interests, the Committee on Foreign Investment in the United States should implement practical enhancements that leverage technology, expertise and clear communication, and enable it to keep pace with evolving demands, says attorney Sohan Dasgupta.

  • Bipartisan Enforcement Is Rising In Consumer Finance

    Author Photo

    Activity over the past year suggests a bipartisan state enforcement wave is rippling across the consumer finance industry, which follows a blueprint set out by former Consumer Financial Protection Bureau Director Rohit Chopra, who notably now leads a Democratic Attorneys General Association working group, say attorneys at Hudson Cook.

  • Series

    Teaching Logic Makes Me A Better Lawyer

    Author Photo

    Teaching middle and high school students the skills to untangle complicated arguments and identify faulty reasoning has made me reacquaint myself with the defined structure of thought, reminding me why logic should remain foundational in the practice of law, says Tom Barrow at Woods Rogers.

  • Series

    Law School's Missed Lessons: Practicing Resilience

    Author Photo

    Resilience is a skill acquired through daily practices that focus on learning from missteps, recovering quickly without internalizing defeat and moving forward with intention, says Nicholas Meza at Quarles & Brady.

  • Upshot Of 'Skinny Label' Case May Go Beyond Pharma

    Author Photo

    The U.S. Supreme Court's pending review of Hikma v. Amarin, over a drugmaker's "skinny label," carries implications for both generics and brand-name pharmaceutical manufacturers, and could shed light on how inducement doctrine should operate in other regulated industries where products have substantial lawful uses, says Jason Shull at Banner Witcoff.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Competition archive.